HELVEPHARM AG
Summary
HELVEPHARM AG is registered in Switzerland and entered in the “UID register” under number CHE-105.859.562. Its legal form is Aktiengesellschaft (AG) – public limited company (Switzerland). According to GLEIF, its ultimate parent is SANOFI (France), which is also its direct parent. That group has 76 subsidiaries with LEIs in 33 countries, 3 of them in Switzerland. The LEI was first issued on 21 Jan 2014 and the record was last updated on 31 Jul 2023. It has lapsed: renewal was due by 14 Nov 2018. GLEIF's ISIN mapping lists 1 ISIN for this LEI. AssetCensus found 3 data-quality notes for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 14 Nov 2018 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
- The ultimate-parent link rests on accounts for the period ending 31 Dec 2016, more than 24 months before this data release. The group may have changed since.
- The ultimate-parent relationship record was not renewed; it was last updated on 31 Jul 2023.
Company details
| Legal form | Aktiengesellschaft (AG) public limited company (Switzerland) |
|---|---|
| Register | UID register · Register website |
| Registration number | CHE-105.859.562 |
| Registration authority | Federal Statistical Office |
| Jurisdiction | Switzerland |
| Registered address | WALZMÜHLESTRASSE 60, 8500 FRAUENFELD, Switzerland |
| Headquarters address | CASE POSTALE 777, 1214 VERNIER, Switzerland |
| Category | company or other legal entity |
| Status | active |
| LEI | 549300TFVBTCM8BM1O45 |
| LEI status | lapsed |
| LEI first issued | 21 Jan 2014 |
| LEI record last updated | 31 Jul 2023 |
| Next LEI renewal | 14 Nov 2018 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Relationship to the parent
| Direct parent | Ultimate parent | |
|---|---|---|
| Parent | SANOFI | SANOFI |
| Accounting period | 1 Jan 2016 to 31 Dec 2016 | 1 Jan 2016 to 31 Dec 2016 |
| Evidence | supporting documents | supporting documents |
| Corroboration | supplied by the entity only | supplied by the entity only |
| Relationship start | 16 Nov 2017 | 16 Nov 2017 |
| Recorded at GLEIF since | 21 Jan 2014 | 21 Jan 2014 |
| Last updated | 31 Jul 2023 | 31 Jul 2023 |
| Record status | not renewed | not renewed |
Other subsidiaries of the same direct parent (36)
- Sanofi-Aventis (Suisse) SA Switzerland
- ABLYNX Belgium
- AZTECA VACUNAS SA DE CV Mexico lapsed
- Carraig Insurance Designated Activity Company Ireland
- CHINOIN GYÓGYSZER-ÉS VEGYÉSZETI TERMÉKEK GYÁRA ZÁRTKÖRŰEN MŰKÖDŐ RT. Hungary lapsed
- GENZYME FLANDERS Belgium
- Hoechst GmbH Germany
- Nattermann Verwaltungs GmbH Germany
- OPELLA HEALTHCARE AUSTRIA GMBH Austria
- OPELLA HEALTHCARE BELGIUM NV/SA Belgium
- OPELLA HEALTHCARE POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Poland
- OPELLA HEALTHCARE SLOVAKIA S.R.O. Slovakia
ISINs mapped to this LEI (1)
CH0010722780
1 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.